IBDEI15Y ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,936,0)
 ;;=UPPER LIMB AMPUTATION STATUS^19^78
 ;;^UTILITY(U,$J,358.4,937,0)
 ;;=LOWER LIMB AMPUTATION STATUS^7^78
 ;;^UTILITY(U,$J,358.4,938,0)
 ;;=UNAVAILABILITY OF MED FACILITY CARE^18^78
 ;;^UTILITY(U,$J,358.4,939,0)
 ;;=CONVALENSCENCE/PALLIATIVE CARE^3^78
 ;;^UTILITY(U,$J,358.4,940,0)
 ;;=NEW PATIENT^2^79
 ;;^UTILITY(U,$J,358.4,941,0)
 ;;=ESTABLISHED PATIENT^1^79
 ;;^UTILITY(U,$J,358.4,942,0)
 ;;=CONSULTATIONS^3^79
 ;;^UTILITY(U,$J,358.4,943,0)
 ;;=PROCEDURES^2^80
 ;;^UTILITY(U,$J,358.4,944,0)
 ;;=COUNSELING/EDUCATION^1^80
 ;;^UTILITY(U,$J,358.4,945,0)
 ;;=PROLONGED SERVICES^3^80
 ;;^UTILITY(U,$J,358.4,946,0)
 ;;=ID-GENERAL^1^81
 ;;^UTILITY(U,$J,358.4,947,0)
 ;;=ID-HIV^2^81
 ;;^UTILITY(U,$J,358.4,948,0)
 ;;=POSTPROCEDURAL INFECTIONS^3^81
 ;;^UTILITY(U,$J,358.4,949,0)
 ;;=BIOPSY^2^82
 ;;^UTILITY(U,$J,358.4,950,0)
 ;;=CENTRAL VENOUS ACCESS PROCEDURES^4^82
 ;;^UTILITY(U,$J,358.4,951,0)
 ;;=PERIPHERAL ANGIOPLASTIES^5^82
 ;;^UTILITY(U,$J,358.4,952,0)
 ;;=PROSTHETIC ANEURYSM REPAIR^6^82
 ;;^UTILITY(U,$J,358.4,953,0)
 ;;=VASCULAR INJECTION PROCEDURES^9^82
 ;;^UTILITY(U,$J,358.4,954,0)
 ;;=BPH^3^82
 ;;^UTILITY(U,$J,358.4,955,0)
 ;;=VERTEBROPLASTY^10^82
 ;;^UTILITY(U,$J,358.4,956,0)
 ;;=ABLATION^1^82
 ;;^UTILITY(U,$J,358.4,957,0)
 ;;=RADIOEMOBOLIZATION PRE/MAPPING^7^82
 ;;^UTILITY(U,$J,358.4,958,0)
 ;;=RADIATION DELIVERY/TREATMENT PLANNING^8^82
 ;;^UTILITY(U,$J,358.4,959,0)
 ;;=NEW PATIENT^2^83
 ;;^UTILITY(U,$J,358.4,960,0)
 ;;=ESTABLISHED PATIENT^1^83
 ;;^UTILITY(U,$J,358.4,961,0)
 ;;=CONSULTATIONS^3^83
 ;;^UTILITY(U,$J,358.4,962,0)
 ;;=COMMON VASCULAR DX^1^84
 ;;^UTILITY(U,$J,358.4,963,0)
 ;;=ABDOMINAL PAIN^2^84
 ;;^UTILITY(U,$J,358.4,964,0)
 ;;=AFTERCARE POST SURGERY^3^84
 ;;^UTILITY(U,$J,358.4,965,0)
 ;;=CARDIOVASCULAR^4^84
 ;;^UTILITY(U,$J,358.4,966,0)
 ;;=GENERAL/SIGNS/SYMPTOMS^5^84
 ;;^UTILITY(U,$J,358.4,967,0)
 ;;=HEMATOLOGY/ONCOLOGY^6^84
 ;;^UTILITY(U,$J,358.4,968,0)
 ;;=INFECTIOUS DISEASE^7^84
 ;;^UTILITY(U,$J,358.4,969,0)
 ;;=METASTATIC CANCER SITES^8^84
 ;;^UTILITY(U,$J,358.4,970,0)
 ;;=POST-OP COMPLICATIONS^9^84
 ;;^UTILITY(U,$J,358.4,971,0)
 ;;=RESPIRATORY^10^84
 ;;^UTILITY(U,$J,358.4,972,0)
 ;;=MFH-NON CLINICIAN VISIT ^2^85
 ;;^UTILITY(U,$J,358.4,973,0)
 ;;=NURSING PROCEDURES^3^85
 ;;^UTILITY(U,$J,358.4,974,0)
 ;;=SPLINTS^4^85
 ;;^UTILITY(U,$J,358.4,975,0)
 ;;=MFH-CLINICIAN VISIT ^1^85
 ;;^UTILITY(U,$J,358.4,976,0)
 ;;=VACCINE ADMINISTRATION^5^85
 ;;^UTILITY(U,$J,358.4,977,0)
 ;;=VACCINES^6^85
 ;;^UTILITY(U,$J,358.4,978,0)
 ;;=PC COMMON DIAGNOSES^1^86
 ;;^UTILITY(U,$J,358.4,979,0)
 ;;=ADMINISTRATIVE TOPICS^2^86
 ;;^UTILITY(U,$J,358.4,980,0)
 ;;=ANGINA^3^86
 ;;^UTILITY(U,$J,358.4,981,0)
 ;;=ATHEROSCLEROSIS^4^86
 ;;^UTILITY(U,$J,358.4,982,0)
 ;;=CARDIOVASCULAR^5^86
 ;;^UTILITY(U,$J,358.4,983,0)
 ;;=DERMATOLOGY^9^86
 ;;^UTILITY(U,$J,358.4,984,0)
 ;;=EAR DISORDERS^10^86
 ;;^UTILITY(U,$J,358.4,985,0)
 ;;=EENT^11^86
 ;;^UTILITY(U,$J,358.4,986,0)
 ;;=ENDOCRINE/METABOLIC^12^86
 ;;^UTILITY(U,$J,358.4,987,0)
 ;;=EYE DISORDERS^13^86
 ;;^UTILITY(U,$J,358.4,988,0)
 ;;=EYE INJURY^14^86
 ;;^UTILITY(U,$J,358.4,989,0)
 ;;=GASTROENTEROLOGY^15^86
 ;;^UTILITY(U,$J,358.4,990,0)
 ;;=GU/RENAL^16^86
 ;;^UTILITY(U,$J,358.4,991,0)
 ;;=HEADACHE^17^86
 ;;^UTILITY(U,$J,358.4,992,0)
 ;;=HEART FAILURE^18^86
 ;;^UTILITY(U,$J,358.4,993,0)
 ;;=HEART VALVE DISEASE^19^86
 ;;^UTILITY(U,$J,358.4,994,0)
 ;;=HEMATOLOGY/ONCOLOGY^20^86
 ;;^UTILITY(U,$J,358.4,995,0)
 ;;=HISTORY OF ILLNESS^21^86
 ;;^UTILITY(U,$J,358.4,996,0)
 ;;=INFECTIOUS DISEASE^22^86
 ;;^UTILITY(U,$J,358.4,997,0)
 ;;=LIVER DISEASE^23^86
 ;;^UTILITY(U,$J,358.4,998,0)
 ;;=MENTAL HEALTH^25^86
 ;;^UTILITY(U,$J,358.4,999,0)
 ;;=MOVEMENT DISORDERS^26^86
 ;;^UTILITY(U,$J,358.4,1000,0)
 ;;=MUSCULOSKELETAL^27^86
 ;;^UTILITY(U,$J,358.4,1001,0)
 ;;=NEUROLOGY^28^86
 ;;^UTILITY(U,$J,358.4,1002,0)
 ;;=PAIN^29^86
 ;;^UTILITY(U,$J,358.4,1003,0)
 ;;=PREVENTIVE HEALTH^30^86
 ;;^UTILITY(U,$J,358.4,1004,0)
 ;;=PULMONARY^31^86
 ;;^UTILITY(U,$J,358.4,1005,0)
 ;;=SEXUAL TRAUMA^32^86
 ;;^UTILITY(U,$J,358.4,1006,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^33^86
 ;;^UTILITY(U,$J,358.4,1007,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^34^86
 ;;^UTILITY(U,$J,358.4,1008,0)
 ;;=SUBSTANCE DISORDERS^35^86
 ;;^UTILITY(U,$J,358.4,1009,0)
 ;;=VARICOSE VEINS^36^86
 ;;^UTILITY(U,$J,358.4,1010,0)
 ;;=WOMEN'S HEALTH^37^86
 ;;^UTILITY(U,$J,358.4,1011,0)
 ;;=WOUNDS-INITIAL ENCOUNTER^38^86
 ;;^UTILITY(U,$J,358.4,1012,0)
 ;;=COMA^7^86
 ;;^UTILITY(U,$J,358.4,1013,0)
 ;;=CAUSES OF INJURY^6^86
 ;;^UTILITY(U,$J,358.4,1014,0)
 ;;=DEMENTIA^8^86
 ;;^UTILITY(U,$J,358.4,1015,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^24^86
 ;;^UTILITY(U,$J,358.4,1016,0)
 ;;=NEW PATIENT^2^87
 ;;^UTILITY(U,$J,358.4,1017,0)
 ;;=ESTABLISHED PATIENT^1^87
 ;;^UTILITY(U,$J,358.4,1018,0)
 ;;=CONSULTATIONS^3^87
 ;;^UTILITY(U,$J,358.4,1019,0)
 ;;=IMMUNIZATIONS^2^88
 ;;^UTILITY(U,$J,358.4,1020,0)
 ;;=INJECTION^3^88
 ;;^UTILITY(U,$J,358.4,1021,0)
 ;;=SKIN TESTS^10^88
 ;;^UTILITY(U,$J,358.4,1022,0)
 ;;=NURSING PROCEDURES^5^88
 ;;^UTILITY(U,$J,358.4,1023,0)
 ;;=MINOR PROCEDURES^4^88
 ;;^UTILITY(U,$J,358.4,1024,0)
 ;;=SPLINTS^10^88
 ;;^UTILITY(U,$J,358.4,1025,0)
 ;;=REPAIR-SIMPLE SCALP,NK,TRUNK,GENTIALS^9^88
 ;;^UTILITY(U,$J,358.4,1026,0)
 ;;=REPAIR-SIMPLE FACE,MUCOUS^8^88
 ;;^UTILITY(U,$J,358.4,1027,0)
 ;;=PREVENTIVE MED-EST PT^6^88
 ;;^UTILITY(U,$J,358.4,1028,0)
 ;;=PREVENTIVE MED-NEW PT^7^88
 ;;^UTILITY(U,$J,358.4,1029,0)
 ;;=IMMUNIZATION ADMIN^1^88
 ;;^UTILITY(U,$J,358.4,1030,0)
 ;;=PC COMMON DIAGNOSES^1^89
 ;;^UTILITY(U,$J,358.4,1031,0)
 ;;=ADMINISTRATIVE TOPICS^2^89
 ;;^UTILITY(U,$J,358.4,1032,0)
 ;;=ANGINA^3^89
 ;;^UTILITY(U,$J,358.4,1033,0)
 ;;=ATHEROSCLEROSIS^4^89
 ;;^UTILITY(U,$J,358.4,1034,0)
 ;;=CARDIOVASCULAR^5^89
 ;;^UTILITY(U,$J,358.4,1035,0)
 ;;=DERMATOLOGY^9^89
 ;;^UTILITY(U,$J,358.4,1036,0)
 ;;=EAR DISORDERS^10^89
 ;;^UTILITY(U,$J,358.4,1037,0)
 ;;=EENT^11^89
 ;;^UTILITY(U,$J,358.4,1038,0)
 ;;=ENDOCRINE/METABOLIC^12^89
 ;;^UTILITY(U,$J,358.4,1039,0)
 ;;=EYE DISORDERS^13^89
 ;;^UTILITY(U,$J,358.4,1040,0)
 ;;=EYE INJURY^14^89
 ;;^UTILITY(U,$J,358.4,1041,0)
 ;;=GASTROENTEROLOGY^15^89
 ;;^UTILITY(U,$J,358.4,1042,0)
 ;;=GU/RENAL^16^89
 ;;^UTILITY(U,$J,358.4,1043,0)
 ;;=HEADACHE^17^89
 ;;^UTILITY(U,$J,358.4,1044,0)
 ;;=HEART FAILURE^18^89
 ;;^UTILITY(U,$J,358.4,1045,0)
 ;;=HEART VALVE DISEASE^19^89
 ;;^UTILITY(U,$J,358.4,1046,0)
 ;;=HEMATOLOGY/ONCOLOGY^20^89
 ;;^UTILITY(U,$J,358.4,1047,0)
 ;;=HISTORY OF ILLNESS^21^89
 ;;^UTILITY(U,$J,358.4,1048,0)
 ;;=INFECTIOUS DISEASE^22^89
 ;;^UTILITY(U,$J,358.4,1049,0)
 ;;=LIVER DISEASE^23^89
 ;;^UTILITY(U,$J,358.4,1050,0)
 ;;=MENTAL HEALTH^25^89
 ;;^UTILITY(U,$J,358.4,1051,0)
 ;;=MOVEMENT DISORDERS^26^89
 ;;^UTILITY(U,$J,358.4,1052,0)
 ;;=MUSCULOSKELETAL^27^89
 ;;^UTILITY(U,$J,358.4,1053,0)
 ;;=NEUROLOGY^28^89
 ;;^UTILITY(U,$J,358.4,1054,0)
 ;;=PAIN^29^89
 ;;^UTILITY(U,$J,358.4,1055,0)
 ;;=PREVENTIVE HEALTH^30^89
 ;;^UTILITY(U,$J,358.4,1056,0)
 ;;=PULMONARY^31^89
 ;;^UTILITY(U,$J,358.4,1057,0)
 ;;=SEXUAL TRAUMA^32^89
 ;;^UTILITY(U,$J,358.4,1058,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^33^89
 ;;^UTILITY(U,$J,358.4,1059,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^34^89
 ;;^UTILITY(U,$J,358.4,1060,0)
 ;;=SUBSTANCE DISORDERS^35^89
 ;;^UTILITY(U,$J,358.4,1061,0)
 ;;=VARICOSE VEINS^36^89
 ;;^UTILITY(U,$J,358.4,1062,0)
 ;;=WOMEN'S HEALTH^37^89
 ;;^UTILITY(U,$J,358.4,1063,0)
 ;;=WOUNDS-INITIAL ENCOUNTER^38^89
 ;;^UTILITY(U,$J,358.4,1064,0)
 ;;=COMA^7^89
 ;;^UTILITY(U,$J,358.4,1065,0)
 ;;=CAUSES OF INJURY^6^89
 ;;^UTILITY(U,$J,358.4,1066,0)
 ;;=DEMENTIA^8^89
 ;;^UTILITY(U,$J,358.4,1067,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^24^89
 ;;^UTILITY(U,$J,358.4,1068,0)
 ;;=OTHER CODES^9^90
 ;;^UTILITY(U,$J,358.4,1069,0)
 ;;=MENTAL HEALTH INTAKE CODES^8^90
 ;;^UTILITY(U,$J,358.4,1070,0)
 ;;=OTHER PSYCHOTHERAPY^9^90
